OrbiMed’s DYAX CORPORATION DYAX Stock Holding History

OrbiMed’s Portfolio DYAX Stock Details DYAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,117,000	Closed	-$21.3M	–	138
2015 Q3	$21.3M	Hold	1,117,000	–	–	0.22%	68
2015 Q2	$29.6M	Buy	+1,117,000	New	+$29.6M	0.25%	71

Other funds holding DYAX

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed's DYAX Position: Q4 2015 in Review

OrbiMed sold out of DYAX CORPORATION (DYAX) in Q4 2015, closing a stake of 1,117,000 shares — an estimated $21.3M sold.

OrbiMed first reported a position in DYAX in Q2 2015 and held it in 2 quarters. The position peaked at $29.6M in Q2 2015. 206 funds tracked by Wall St. Rank hold DYAX as of Q4 2015.

OrbiMed reported no remaining DYAX CORPORATION position as of Q4 2015 after selling out during the quarter.
OrbiMed sold 1,117,000 DYAX CORPORATION shares in Q4 2015, an estimated $21.3M.
OrbiMed first reported a position in DYAX CORPORATION in Q2 2015 and held it in 2 quarters.
OrbiMed's DYAX CORPORATION position peaked at $29.6M in Q2 2015.
206 funds tracked by Wall St. Rank held DYAX CORPORATION as of Q4 2015.

Based on OrbiMed's 13F filing for Q4 2015, filed 16 Feb 2016.